Considering the reasons mentioned above, the concerned study was carried out based on the following components: (1) Microarray used to screen the differential highly expressed genes with unknown function in prostate between wild type mice and KIMAP prostate cancer mouse model (by 20th week and 60th week).

Transurethral plasmakinetic resection of prostate for treatment of benign prostatic hyperplasia;

Transurethral electro resection for prostatic hyperplasia with small volume:A report 30 cases;

A comparative study and evaluations on the results of TURP and transrectal high intensity focused ultrasound (HIFU) for the treatment of benign prostatic hyperplasia;

The significance of fibroblast growth factor 7 mRNA expression in benign prostate hyperplasia tissue;

Expression effect study of Xianjia prescription on prostate s bcl-2 and bax in benign prostate hyperplasia rats;

Detection of serum prostate specific antigen in cases of prostate hyperplasia;

Treatment of senior and high risk benign prostatic hyperplasia by transurethral electrovaporization and resection of prostate;

Effect of Xianjia prescription on the expression of FAS in rats prostate exponent of benign prostatic hyperplasia;

Transurethral electrovaporization of prostate for treatment of benign prostatic hyperplasia and management of its complications(a report of 612 cases);